Welcome to LookChem.com Sign In|Join Free
  • or
2-(2,3-Dihydro-1H-indol-1-yl)-5-(trifluoromethyl)-phenylamine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

73551-84-5

Post Buying Request

73551-84-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

73551-84-5 Usage

Molecular structure

2-(2,3-Dihydro-1H-indol-1-yl)-5-(trifluoromethyl)-phenylamine is an organic compound with a core structure that includes a dihydroindole ring and a phenyl ring connected by an amine group, with a trifluoromethyl group attached to the phenyl ring.

Versatile building block

TPA is a versatile building block for various organic synthesis reactions, making it widely used in the pharmaceutical industry for the production of potential drug candidates and in agrochemical research for the development of new pesticides.

Key intermediate

TPA is a key intermediate in the synthesis of fluorescent dyes, polymers, and other specialty chemicals, making it a valuable tool in chemical research and development.

Stability and lipophilicity

The trifluoromethyl group in TPA contributes to the compound's stability and lipophilicity, which are favorable properties in many applications.

Check Digit Verification of cas no

The CAS Registry Mumber 73551-84-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,5,5 and 1 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 73551-84:
(7*7)+(6*3)+(5*5)+(4*5)+(3*1)+(2*8)+(1*4)=135
135 % 10 = 5
So 73551-84-5 is a valid CAS Registry Number.

73551-84-5Downstream Products

73551-84-5Relevant academic research and scientific papers

METHOD OF REGULATING PHOSPHORYLATION OF SR PROTEIN AND ANTIVIRAL AGENTS COMPRISING SR PROTEIN ACTIVITY REGULATOR AS THE ACTIVE INGREDIENT

-

Page/Page column 45, (2008/06/13)

The present invention provides: (1) antiviral agents that act by reducing or inhibiting the activity of SR proteins, more specifically, (i) antiviral agents that act by enhancing dephosphorylation of SR proteins, and (ii) antiviral agents that act by inhi

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 73551-84-5